Advertisement
Screener

Opus Genetics, Inc. (IRD) Net Margin

Opus Genetics, Inc. (IRD) Net Margin

  • 2026-06-30: Net Margin -1072.58%.
  • 2026-03-31: Net Margin -3038.25%.
  • 2025-12-31: Net Margin -427.50%.
  • 2025-09-30: Net Margin -566.87%.

Complete source-backed net margin history.

Available history
2010-06-30 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-30-1072.58%
2026-03-31-3038.25%
2025-12-31-427.50%
2025-09-30-566.87%
2025-06-30-257.46%
2025-03-31-187.51%
2024-12-31-816.71%
2024-09-30-194.62%
2024-06-30-698.29%
2024-03-31-415.31%
2023-12-31-283.56%
2023-09-3046.59%
2023-06-30-135.03%
2023-03-31-331.10%
2022-12-3185.17%
2021-09-30-865.03%
2021-06-30-7136.00%
2020-03-31-268.52%
2019-03-31-78.10%
2010-06-30-19184.37%

Annual Net Margin

DateNet Margin
2025-12-31-349.33%
2024-12-31-523.40%
2023-12-31-52.42%
2022-12-3144.89%
2021-12-31-9625.30%
2019-12-31-205.63%

Similar stocks

Stock NameCountryMarket CapPE Ratio
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
Turn Therapeutics Inc. (TTRX)United States$0.397B-25.68
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
Rezolute, Inc. (RZLT)United States$0.382B-6.45
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63